« Previous
Next »
Journal of Psychosomatic Research
Volume 61, Issue 4
, Pages 453-460
, October 2006
Effects of corticotropin-releasing hormone (CRH) on endothelin-1 and NO release, mediated by CRH receptor subtype R2: A potential link between stress and endothelial dysfunction?
References
- . Atherosclerosis—an inflammatory disease. N Engl J Med. 1999;340:115–126
- . Immunomodulation of atherosclerosis: implications for vaccine development. Arterioscler Thromb Vasc Biol. 2005;25:18–28
- . Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation. 1999;99:2192–2217
- . Psychosocial influences on mortality after myocardial infarction. N Engl J Med. 1984;311:552–559
- Chronic life stress alters sympathetic, neuroendocrine, and immune responsivity to an acute psychological stressor in humans. Psychosom Med. 1997;59:447–457
- . Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science. 1981;213:1394–1397
- . Peripheral corticotropin-releasing hormone and urocortin in the control of the immune response. Peptides. 2001;22:809–820
- . Stress and the hypothalamo-pituitary–adrenal axis: acute, chronic and immunological activation. J Endocrinol. 1992;134:327–339
- . Involvement of corticotropin-releasing hormone- and interlukin (IL)-6-dependent proopiomelanocortin induction in the anterior pituitary during hypothalamic–pituitary–adrenal axis activation by IL-1{alpha}. Endocrinology. 2005;5496–5502
- . Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685–1695
- Mechanisms underlying the anti-inflammatory actions of central corticotropin-releasing factor. Am J Physiol. 1999;276(4 Pt 1):G1016–G1026
- Corticotropin-releasing hormone contributes to the peripheral inflammatory response in experimental autoimmune encephalomyelitis. J Immunol. 2005;174:5407–5413
- . Corticotropin-releasing factor receptors: an overview. Exp Clin Endocrinol Diabetes. 1997;105:65–82
- . The central nervous system and atherogenesis: interrelationships. Adv Exp Med Biol. 1990;273:359–380
- . Psychosocial factors impair vascular responses of coronary arteries. Circulation. 1991;84:2146–2153
- A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411–415
- . Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation. 1995;92:2426–2431
- . Increased endothelin plasma concentrations in patients with coronary artery disease or hyperlipoproteinemia without coronary events. Res Exp Med (Berl). 1993;193:225–230
- . Immunoreactive endothelin in human plasma, urine, milk, and saliva. J Cardiovasc Pharmacol. 1991;17(Suppl 7):S390–S393
- Circulating immunoreactive endothelin in ischemic heart disease. Am Heart J. 1990;119:801–806
- . Endothelin-1 induces CD40 but not IL-6 in human monocytes via the proinflammatory transcription factor NF-kappaB. Eur J Med Res. 2005;10:197–201
- Conditional cardiac overexpression of endothelin-1 induces inflammation and dilated cardiomyopathy in mice. Circulation. 2004;109:255–261
- Endothelin-1 response to mental stress in early ischemic lesions of the extremities due to systemic sclerosis. Peptides. 2005;26:2487–2490
- Impaired renal adaptation to stress in the elderly with isolated systolic hypertension. Hypertension. 1999;34:1106–1111
- . The pathogenesis of cardiovascular disease: role of the endothelium as a target and mediator. Atherosclerosis. 1995;118(Suppl):S81–S90
- . Effects of corticotropin-releasing hormone (CRH) on monocyte function, mediated by CRH-receptor subtype R1 and R2: a potential link between mood disorders and endothelial dysfunction?. J Cardiovasc Pharmacol. 2006;47:110–116[in press]
- . Cocaine increases the endothelial release of immunoreactive endothelin and its concentrations in human plasma and urine: reversal by coincubation with sigma-receptor antagonists. Circulation. 1998;98:385–390
- Human umbilical vein endothelial cells: a new source and potential target for corticotropin-releasing factor. J Clin Endocrinol Metab. 1999;84:2802–2806
- . Arginine–vasopressin and corticotropin-releasing hormone are sequentially involved in the endothelin-1-induced acute stimulation of rat pituitary–adrenocortical axis. J Steroid Biochem Mol Biol. 1998;66:45–49
- Divergent effects of corticotropin releasing hormone on endothelial cell nitric oxide synthase are associated with different expression of CRH type 1 and 2 receptors. Br J Pharmacol. 2001;134:837–844
- . Endothelium-dependent and -independent mechanisms of vasorelaxation by corticotropin-releasing factor in pregnant rat uterine artery. J Pharmacol Exp Ther. 1999;288:407–413
- . Cardiovascular actions of CRH and urocortin: an update. Peptides. 2001;22:821–827
- . Corticotropin-releasing hormone in humans. Endocr Rev. 1992;13:164–191
- . Radioimmunoassay of corticotropin-releasing hormone. Exp Clin Endocrinol. 1990;96:129–137
- . Direct measurement of human plasma corticotropin-releasing hormone by “two-site” immunoradiometric assay. J Clin Endocrinol Metab. 1987;64:1047–1053
- Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors. FASEB J. 2001;15:1678–1693
- . Endothelial dysfunction in human disease. J Mol Cell Cardiol. 1999;31:51–60
- Mental stress induces prolonged endothelial dysfunction via endothelin-A receptors. Circulation. 2002;105:2817–2820
- . Corticotropin-releasing hormone augments proinflammatory cytokine production from macrophages in vitro and in lipopolysaccharide-induced endotoxin shock in mice. Infect Immun. 2002;70:6068–6074
- . Effect of endothelin antagonism on the production of cytokines in eosinophilic airway inflammation. Am J Physiol Lung Cell Mol Physiol. 2001;280:L659–L665
☆ This work contains data from a doctoral thesis by M. Modrzik and B. Fiedler of Ludwig-Maximilian-Universität.
PII: S0022-3999(06)00305-9
doi: 10.1016/j.jpsychores.2006.07.001
© 2006 Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Psychosomatic Research
Volume 61, Issue 4
, Pages 453-460
, October 2006
